Ripple Therapeutics is a clinical stage ophthalmic therapeutics company focused on sustained drug delivery without the use of polymers. Our platform prodrug technology generates composition of matter IP. These novel therapeutics provide better outcomes for patients, easier management of care for physicians and lower costs for payors.